Concomitant imatinib and ibrutinib in a patient with chronic myelogenous leukemia and chronic lymphocytic leukemia

por Shea, Lauren K., Mikhail, Fady M., Forero‐Torres, Andres, Davis, Randall S.
Publicado 2017

Fc receptor-like 2 (FCRL2) is a novel marker of low-risk CLL and refines prognostication based on IGHV mutation status

por Shea, Lauren K., Honjo, Kazuhito, Redden, David T., Tabengwa, Edlue, Li, Ran, Li, Fu-Jun, Shakhmatov, Mikhail, Chiorazzi, Nicholas, Davis, Randall S.
Publicado 2019

The ARF Tumor Suppressor Regulates Bone Remodeling and Osteosarcoma Development in Mice

por Rauch, Daniel A., Hurchla, Michelle A., Harding, John C., Deng, Hongju, Shea, Lauren K., Eagleton, Mark C., Niewiesk, Stefan, Lairmore, Michael D., Piwnica-Worms, David, Rosol, Thomas J., Weber, Jason D., Ratner, Lee, Weilbaecher, Katherine N.
Publicado 2010

Cancer Exome Analysis Reveals a T Cell Dependent Mechanism of Cancer Immunoediting

por Matsushita, Hirokazu, Vesely, Matthew D., Koboldt, Daniel C., Rickert, Charles G., Uppaluri, Ravindra, Magrini, Vincent J., Arthur, Cora D., White, J. Michael, Chen, Yee-Shiuan, Shea, Lauren K., Hundal, Jasreet, Wendl, Michael C., Demeter, Ryan, Wylie, Todd, Allison, James P., Smyth, Mark J., Old, Lloyd J., Mardis, Elaine R., Schreiber, Robert D.
Publicado 2012